Alzheimer expertise Compass Research specializes in multi-therapeutic clinical trials with a strong emphasis on Alzheimer's disease and neurodegenerative research, presenting opportunities for sponsors seeking domain-specific sites with patient access and specialized trial execution.

Regional footprint Headquartered in Orlando with additional sites in The Villages and Melbourne, Compass offers coast-to-coast Florida coverage for outpatient and inpatient studies, enabling trials with diverse patient populations and streamlined site logistics.

End-to-end capability Capability across all phases of research (phases 0-4) coupled with board-certified physicians and experienced clinical research coordinators supports a wide range of study designs, potentially reducing sponsor timelines and coordination effort.

Proven trial velocity With over 1,300 completed trials and collaboration with more than 200 industry sponsors, Compass demonstrates a track record of execution and sponsor satisfaction, a compelling credential for new business development.

Growth-ready scale Moderate size relative to mega CROs positions Compass as a flexible partner with potential for scalable collaboration, bundled service offerings, and targeted expansions in neurodegenerative and multi-therapeutic programs.